Eam Investors, LLC Axonics, Inc. Transaction History

Eam Investors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $1.39 Million - $1.87 Million	23,934 New	23,934 $1.69 Million
Q4 2021 Feb 11, 2022	SELL	$50.01 - $73.35 $1.35 Million - $1.99 Million	-27,094 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $1.6 Million - $2.13 Million	27,094 New	27,094 $1.76 Million
Q4 2020 Feb 11, 2021	SELL	$42.19 - $51.5 $1.23 Million - $1.5 Million	-29,127 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$35.33 - $51.04 $1.03 Million - $1.49 Million	29,127 New	29,127 $1.49 Million
Q4 2019 Feb 11, 2020	SELL	$19.57 - $28.96 $1.62 Million - $2.4 Million	-82,757 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$26.92 - $42.41 $14,213 - $22,392	-528 Reduced 0.63%	82,757 $2.23 Million
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $654,313 - $1.45 Million	35,292 Added 73.54%	83,285 $3.41 Million
Q1 2019 May 13, 2019	BUY	$13.32 - $24.35 $639,266 - $1.17 Million	47,993 New	47,993 $1.15 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.